Sermorelin

Growth Hormone SecretagogueResearch Use Only

Also known as: GRF 1-29, GHRH 1-29, Sermorelin acetate

Sermorelin is a GHRH analog consisting of the first 29 amino acids of human growth-hormone-releasing hormone, commonly referenced in research literature for stimulating endogenous growth-hormone secretion. Historically it has been studied in the context of growth-hormone axis assessment. This entry is educational and research-use-only and is not medical advice.

Typical range (research)

Commonly referenced in literature around 100–300 mcg per administration, typically once daily (research reference only)

Half-life

~10–20 minutes (very short-acting)

Route

Subcutaneous (research)

Common use

Studied as a GHRH analog for stimulating natural growth-hormone release in research

Common vial sizes

5 mg · 10 mg

Storage

Lyophilized powder stored refrigerated or frozen away from light; reconstituted solution refrigerated (2–8 °C) and used within a few weeks

Stacking notes

Commonly paired with a GHRP such as GHRP-2 or Ipamorelin in research protocols

Reported side effects

Injection-site reactionFlushing reported anecdotallyTransient headache reported anecdotally

Regulatory note: Previously an approved diagnostic agent in some jurisdictions; current research-market products are sold for research purposes only

Calculate a dose →

Dose figures are ranges commonly referenced in research literature, not recommendations or medical advice. Not for human or veterinary use. Consult a licensed physician.